Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
+8
Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
Not recruiting
Investigated Drugs:
+2
Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions
Not recruiting
Investigated Drugs:
+1
Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effects of Chemotherapy and Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Using Tamoxifen and Anastrozole
Not recruiting
Investigated Diseases:Investigated Drugs:
